New Drugs, Fair Prices: Managing the Pharmaceutical Innovation Ecosystem for Sustainable and Affordable New Medicines

The book provides a balanced and comprehensive understanding of pharmaceutical innovation, recognizing the need for affordability and investment into innovation. It is original in its approach, using ecological concepts to understand pharmaceutical innovation as an ecosystem, and unique in its research foundation, drawing on the views of over 70 expert informants from all parts of the pharmaceutical innovation ecosystem.

Format: Hardback
Length: 306 pages
Publication date: 21 November 2022
Publisher: Taylor & Francis Ltd

The book stands out as a balanced and comprehensive exploration of the pharmaceutical innovation landscape, recognizing the crucial interplay between affordability and investment in innovation. It goes beyond conventional approaches by employing ecological concepts to understand pharmaceutical innovation as an intricate ecosystem. This unique perspective offers a fresh and insightful understanding of the complex dynamics at play within the pharmaceutical industry.

One of the book's most remarkable features is its robust research foundation. Drawing upon the insights and perspectives of over 70 expert informants from diverse segments of the pharmaceutical innovation ecosystem and across different viewpoints on drug pricing, the book provides a comprehensive and multifaceted analysis. This extensive range of perspectives ensures that a wide range of insights and viewpoints are captured, fostering a deeper understanding of the complex challenges and opportunities facing the pharmaceutical industry.

The book's chapters are organized in a logical and coherent manner, making it easy to navigate and grasp the key themes and arguments presented. Each chapter begins with an introduction that sets the stage for the subsequent discussion, providing context and highlighting the relevance of the topic at hand. The chapters are further enriched with case studies, examples, and empirical evidence, which help to illustrate the practical applications of the theoretical concepts discussed.

Throughout the book, the authors emphasize the importance of collaboration and cooperation among stakeholders in the pharmaceutical innovation ecosystem. They argue that by working together, stakeholders can foster innovation, improve access to healthcare, and ensure that drugs are priced fairly and sustainably. The book also highlights the role of government policies and regulations in shaping the pharmaceutical innovation landscape and discusses the potential for public-private partnerships to drive positive change.

In conclusion, The Pharmaceutical Innovation Ecosystem: Balancing Affordability and Investment is a groundbreaking work that offers a fresh and insightful perspective on pharmaceutical innovation. Through its comprehensive research foundation, engaging writing style, and thought-provoking arguments, the book provides valuable insights for policymakers, industry professionals, and anyone interested in understanding the complex dynamics of the pharmaceutical industry. This book is a must-read for anyone seeking to navigate the challenges and opportunities of pharmaceutical innovation in the 21st century.

Weight: 760g
Dimension: 234 x 156 (mm)
ISBN-13: 9781032352237